Skip to main content
user-generated· regulatory

WHO to prequalify Island Pharma’s Ebola drug by 2026-12-31

Emergency use approval often precedes WHO prequalification, a critical step for global distribution. Given the urgent public health context, WHO may expedite review and grant prequalification within 6 months of the emergency authorization.

regulatory · Prediction Market

Implied probability (Yes)
60%
Closes
2026-12-31

More regulatory markets

Browse all regulatory markets →

Loading…